516 related articles for article (PubMed ID: 23642375)
1. Short-term consumption of oral omega-3 and dry eye syndrome.
Kangari H; Eftekhari MH; Sardari S; Hashemi H; Salamzadeh J; Ghassemi-Broumand M; Khabazkhoob M
Ophthalmology; 2013 Nov; 120(11):2191-6. PubMed ID: 23642375
[TBL] [Abstract][Full Text] [Related]
2. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye.
Bhargava R; Kumar P; Phogat H; Kaur A; Kumar M
Cont Lens Anterior Eye; 2015 Jun; 38(3):206-10. PubMed ID: 25697893
[TBL] [Abstract][Full Text] [Related]
3. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.
Wojtowicz JC; Butovich I; Uchiyama E; Aronowicz J; Agee S; McCulley JP
Cornea; 2011 Mar; 30(3):308-14. PubMed ID: 21045648
[TBL] [Abstract][Full Text] [Related]
4. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers.
Bhargava R; Kumar P
Cornea; 2015 Apr; 34(4):413-20. PubMed ID: 25719253
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE
Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users.
Bhargava R; Kumar P; Arora Y
Eye Contact Lens; 2016 Jul; 42(4):231-6. PubMed ID: 26322917
[TBL] [Abstract][Full Text] [Related]
7. Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes.
Epitropoulos AT; Donnenfeld ED; Shah ZA; Holland EJ; Gross M; Faulkner WJ; Matossian C; Lane SS; Toyos M; Bucci FA; Perry HD
Cornea; 2016 Sep; 35(9):1185-91. PubMed ID: 27442314
[TBL] [Abstract][Full Text] [Related]
8. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes.
Kallarackal GU; Ansari EA; Amos N; Martin JC; Lane C; Camilleri JP
Eye (Lond); 2002 Sep; 16(5):594-600. PubMed ID: 12194075
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms.
Bhargava R; Chandra M; Bansal U; Singh D; Ranjan S; Sharma S
Curr Eye Res; 2016 Oct; 41(10):1274-1280. PubMed ID: 27050028
[TBL] [Abstract][Full Text] [Related]
10. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.
Souied EH; Delcourt C; Querques G; Bassols A; Merle B; Zourdani A; Smith T; Benlian P;
Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546
[TBL] [Abstract][Full Text] [Related]
11. [Taufon use in myopic contact lens wearers].
Naumenko VV; Pogosian MA; Sergeev VP
Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
[TBL] [Abstract][Full Text] [Related]
12. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.
; Asbell PA; Maguire MG; Pistilli M; Ying GS; Szczotka-Flynn LB; Hardten DR; Lin MC; Shtein RM
N Engl J Med; 2018 May; 378(18):1681-1690. PubMed ID: 29652551
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
Ozen S; Ozer MA; Akdemir MO
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
[TBL] [Abstract][Full Text] [Related]
14. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
Cömez AT; Tufan HA; Kocabıyık O; Gencer B
Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients.
Brignole-Baudouin F; Baudouin C; Aragona P; Rolando M; Labetoulle M; Pisella PJ; Barabino S; Siou-Mermet R; Creuzot-Garcher C
Acta Ophthalmol; 2011 Nov; 89(7):e591-7. PubMed ID: 21834921
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
Liew SH; Nichols KK; Klamerus KJ; Li JZ; Zhang M; Foulks GN
Ophthalmology; 2012 Jul; 119(7):1328-35. PubMed ID: 22525048
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study.
Chinnery HR; Naranjo Golborne C; Downie LE
Ophthalmic Physiol Opt; 2017 Jul; 37(4):473-481. PubMed ID: 28295445
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids supplements for dry eye - Are they effective or ineffective?
Bhargava R; Pandey K; Ranjan S; Mehta B; Malik A
Indian J Ophthalmol; 2023 Apr; 71(4):1619-1625. PubMed ID: 37026312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
